文献速递复苏、休克与脓毒症

应用AED但未建议除颤——丹麦心脏骤停登记处新变量AED的验证研究

AED applied, not recommending defibrillation - A validation study of the new variable AED in the Danish Cardiac Arrest Registry.
PubMed 文献 · Resuscitation · 2023-02-09
一句话结论丹麦心脏骤停登记处验证新变量AED:应用AED并除颤者30天生存率35.2%,未除颤者18%,提示需统一院外心脏骤停报告。

该验证研究纳入2016至2019年丹麦心脏骤停登记处全部院外心脏骤停患者,通过病历审查建立AED变量。共纳入1576例,其中747例应用AED并接受电击,829例应用AED但未放电。除颤组旁观者目击比例72%(n=541),ROSC率57%、30天生存率35.2%;未除颤组仅47%被目击,18%存活超过30天,P<0.001。比较有AED与无AED两组,AED组更可能被旁观者目击和接受旁观者心肺复苏,初始心律无显著差异;30天生存率AED组20% vs 无AED组14%,OR 1.14(95%CI 1.20-1.66)。

要点

  • 共纳入1576例院外心脏骤停:747例应用AED并接受电击,829例应用AED但未放电,两组临床特征与结局不同。
  • 除颤组旁观者目击541例(72%),ROSC率57%、30天生存率35.2%;未除颤组仅47%被目击、18%存活超过30天,P<0.001。
  • 有AED组较无AED组更可能被旁观者目击和接受旁观者心肺复苏,两组初始心律无显著差异。
  • 30天生存率有AED组20% vs 无AED组14%,OR 1.14(95%CI 1.20-1.66)。
  • 作者认为实施AED变量提高了院外心脏骤停登记完整性,但未来仍需努力改进登记完整性。

适用人群与场景

  • 2016至2019年丹麦心脏骤停登记处全部院外心脏骤停患者。
  • 纳入所有应用AED的患者,并开展对比分析。

研究设计与关键结果

  • 验证研究:共纳入1576例院外心脏骤停,747例应用AED并接受电击,829例应用AED但未放电。
  • 除颤组旁观者目击541例(72%),ROSC率57%,30天生存率35.2%;未除颤组47%被目击,18%存活超过30天,P<0.001。
  • 有AED组较无AED组更可能被旁观者目击和接受旁观者心肺复苏,两组初始心律无显著差异。
  • 30天生存率有AED组20% vs 无AED组14%,OR 1.14(95%CI 1.20-1.66)。

证据类型、等级与局限

  • 证据类型:验证研究(丹麦心脏骤停登记处数据)。
  • 作者指出实施AED变量提高了院外心脏骤停登记完整性,但未来仍需努力改进登记完整性。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为本研究所揭示的接受除颤与未接受除颤的院外心脏骤停患者之间的差异,强调了对院外心脏骤停进行统一报告的必要性。
  • 作者认为实施AED变量提高了院外心脏骤停登记的完整性,但未来仍需努力改进登记完整性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

AIM: This study aimed to design and implement a new variable, the automated external defibrillator (AED) variable, within the Danish Cardiac Arrest Registry. The introduction of the new variable aims to investigate and solve the challenges of reporting out-of-hospital cardiac arrests.

METHODS: This validation study examined all patients with out-of-hospital cardiac arrest from 2016 to 2019. Their medical records were reviewed to establish a variable for AED. All patients with an AED applied were included, and comparative analyses were carried out. The primary outcome was 30-day survival, and the secondary outcome was the return of spontaneous circulation (ROSC) at any time.

RESULTS: A total of 1576 cases were included; of those, 747 cases had an AED applied and received a shock, and in 829 cases, an AED was applied without delivering a shock. Most defibrillated patients were witnessed by bystanders n = 541, (72%). They presented a higher number of ROSC (57%) and higher 30-day survival, (35,2%) compared to patients who were not defibrillated. Of this group, only 47% patients were witnessed; 18% survived more than 30 days, p < 0.001. When comparing AED present with no AED present, the AED group were significantly more likely to be witnessed by bystanders and to have cardiopulmonary resuscitation by bystanders. No significant differences were found regarding the initial rhythm between the two groups. 30-day survival rate was 20% in the AED group compared to 14% in the non-AED group, yielding an OR of 1.14 (95% CI 1.20-1.66).

CONCLUSION: This study highlights the differences between OHCA patients receiving defibrillation and those not receiving defibrillation after AED placement. These differences emphasise the need for uniform reporting of out-of-hospital cardiac arrest. This study showed improvement in the completeness of the registration of OHCA by implementing the AED variable. However, a future effort to improve registration completeness is needed.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Casarini E, Wolthers SA, Ringgren KB, et al. AED applied, not recommending defibrillation - A validation study of the new variable AED in the Danish Cardiac Arrest Registry. Resuscitation. 2023. PMID: 36764572. doi:10.1016/j.resuscitation.2023.109725

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。